Ujvira 100mg Injection

About

Ujvira 100mg Injection is a targeted therapy, specifically a monoclonal antibody, designed to treat certain types of cancer. It works by binding to the human epidermal growth factor receptor 2 (HER2) protein, which is overexpressed on the surface of some cancer cells. This binding action helps to inhibit the growth and proliferation of these cancer cells, leading to their destruction. It is often used in combination with chemotherapy or as a standalone treatment, depending on the specific cancer type and stage. Its mechanism of action is crucial in providing a more precise approach to cancer treatment, minimizing damage to healthy cells compared to traditional chemotherapy.

The administration of Ujvira 100mg Injection is typically intravenous, requiring careful monitoring by healthcare professionals. Its efficacy has been well-established in clinical trials, demonstrating significant improvements in patient outcomes for HER2-positive malignancies. Regular assessments are necessary to monitor treatment response and manage any potential side effects, ensuring optimal therapeutic benefit for patients undergoing this advanced cancer therapy.

Uses

• HER2-positive early breast cancer
• HER2-positive metastatic breast cancer
• HER2-positive metastatic gastric cancer
• HER2-positive metastatic gastroesophageal junction adenocarcinoma

Directions For Use

Administered intravenously by a healthcare professional. Dosage and frequency are determined by the physician based on patient's condition.

Benefits

• Targets specific cancer cells with HER2 overexpression
• Improves progression-free and overall survival
• Can be used as adjuvant or neoadjuvant therapy
• Reduces the risk of cancer recurrence
• Effective in combination with chemotherapy regimens
• Offers a more personalized approach to cancer treatment

Side Effects

• Infusion-related reactions
• Cardiotoxicity (heart problems)
• Diarrhea
• Nausea and vomiting
• Fatigue
• Headache
• Rash
• Fever and chills
• Abdominal pain
• Peripheral neuropathy
• Neutropenia (low white blood cell count)
• Anemia

Safety Measures

• Alcohol - No specific interaction, but generally advised to limit alcohol intake during cancer treatment.
• Pregnancy - Contraindicated during pregnancy as it can cause fetal harm or death. Effective contraception is required.
• Breastfeeding - Not recommended during breastfeeding due to potential for serious adverse reactions in the infant.
• Liver - Use with caution in patients with pre-existing liver conditions; monitor liver function tests regularly.
• Kidney - Use with caution in patients with kidney impairment; monitor renal function as needed.
• Lung - Monitor for signs of pulmonary toxicity, including interstitial lung disease, especially in susceptible patients.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.